Authors
No takes yet. Share an insight, caveat, or question.
Observational cohort study reveals that dynamic interleukin-6 levels track disease severity in severe COVID-19 patients, indicating its utility for clinical monitoring and treatment response.
Liu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: